GPs 'unsupported' to tackle hepatitis C, says charity
By Ayshe Ismail, 11 March 2013
PCTs have not done enough to encourage GP practices to test for hepatitis C and a failure to plan future services could lead to soaring NHS costs, a charity has warned.
There is a shortage of measures to promote testing in GP practices and local authorities are not ready to take responsibility for hepatitis C from April 2013, according to a report published by charity The Hepatitis C Trust.
Only a quarter of local authorities responding to a survey by the charity knew how many people in their area have the infection or are at risk. Almost half (46%) of NHS commissioners had no measures in place to encourage hepatitis testing in local GP practices.
The report, Opportunity knocks? An audit of hepatitis C services during the transition, said: ‘GPs are the first healthcare professionals that people tend to come into contact with, and are therefore in an important position to identify those who might be, or have been, at risk of hepatitis C infection and should be offered a test.’
The RCGP training module on detection, diagnosis and management of hepatitis B and C should be promoted more widely as part of ongoing GP education, the report said.
Charles Gore, chief executive of The Hepatitis C Trust, said: ‘Deaths from liver disease are increasing and within liver disease it is deaths from hepatitis C that are increasing the fastest. Failure to tackle hepatitis C will result in a significant increase in costs to the NHS and wider society.'
He added: ‘We could eradicate hepatitis C in the UK in a generation. What a tragedy to look back in 20 years and realise that we didn’t eradicate it when we had the opportunity.’
- Related Drug Categories
- Viral infections
- Related MIMS Tables
- Routine Childhood Immunisation Schedule
- Summary of Antibiotic Treatments in Adults
- Related MIMS Guidelines and Summaries
- Peginterferon Alfa and Ribavirin for Treating Chronic Hepatitis C in Children and Young People (TA300)
- Colistimethate Sodium and Tobramycin Dry Powders for Inhalation for Treating Pseudomonas Lung Infection in Cystic Fibrosis (TA276)
- Boceprevir for the Treatment of Genotype 1 Chronic Hepatitis C (TA253)
Latest Articles from GP
Latest jobs Jobs web feed
- Part Time GP Partner Springfield Surgery Surrey Set monthly drawings (net of superannuation) + periodic profit share , Between Farnham and Godalming
- Salaried GP Part time Shetland Islands The Scalloway Health Centre £74k per annum pro rata 7 weeks annual leave, 2 weeks , Shetland Islands
- Part Time Salaried GP/GP Partner Standon and Puckeridge Surgery To be discussed at interview, Hertfordshire
- Salaried GP Church Elm Health Centre Dependant upon experience, London/Essex border
- GP Partner Cornishway Group Practice To be discussed, Wythenshawe Manchester
- Clinical Lead GP required in Nottingham, 6 sessions, £80K + Benefits Career Doctors £80K + NHS Pension + 5 weeks annual leave + additional paid study leave, Nottingham